Wearable monitoring devices will lead epilepsy monitoring devices sales through 2036 with a 59.0% share of the leading product segment in 2026. The market is valued at USD 611.4 million in 2026 and is forecast to reach USD 995.9 million by 2036 as ambulatory seizure detection adoption widens.